Company

Pumpkinseed Bio

Pumpkinseed Bio develops nanophotonic technology for protein sequencing and analysis.

About

Founded in 2021, Pumpkinseed Bio develops DeSIPHR, a nanophotonic platform for single-molecule protein sequencing and analysis. Its technology is intended to support drug discovery and biomarker research for biopharma companies, researchers and academic institutions. The company is based in Palo Alto, US. In May 2026, it raised USD 20.00 mn in Series A funding, with participation from Future Ventures, NFX, Adventures, Base4 Capital and Stanford Investment Group.

1Funding rounds

5Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in